Both in Pharmaceuticals

Oruka Therapeutics vs Mirum Pharmaceuticals

Over the past year ORKA returned +269.7% and MIRM returned +36.6%; their daily moves had a correlation of 0.41.

ORKA +269.7% MIRM +36.6%Growth of $1, one year, split-adjusted
MetricORKAMIRM
Price$101.41$96.97
Market cap$6.71B$6.30B
Today+1.87%+11.42%
1 month+26.5%+22.4%
6 months+45.3%−11.9%
Year to date+234.6%+22.8%
1 year+287.2%+36.9%
Revenue growth (YoY)—+39.6%
Gross margin—81.1%
Net margin—−22.0%
P/E (TTM)——
Price / sales—9.4×
Net cash$873.6M-$357.6M
Dividend yield——
Volatility (60d)51.8%44.1%
Short % of float11.5%12.9%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).